Research Reports

Prepared Highlights

Revenue: Q3 2025 revenue of $8.0 million, up 85% year-over-year (CEO) (CFO)
Gross Profit: Non-GAAP gross profit of $1.7 million, representing a 21% gross margin, compared to a loss in the prior year (CEO) (CFO)
Cash Position: Ended Q3 with $648 million in cash, cash equivalents and marketable securities, after completing a warrant dividend and $360M convertible notes offering (CEO) (CFO)
Smartphone Program: Lead smartphone program with Honor entered final validation phase; a design iteration for 1,000 charge-discharge cycles is underway, with samples on track to ship in Q4 (CEO)
Smart Eyewear: Delivered over 1,000 battery packs to lead customer under supply agreement; sampled to 9 other unique OEMs/ODMs, with some product launches expected in 2026 (CEO)
Defense & Industrial: Year-to-date Korea facility shipped roughly $20 million in products, majority to domestic defense/industrial customers; global pipeline of opportunities growing to over $80 million (CEO)
Manufacturing Progress: Yield improvements in Fab2 (Malaysia) across all production zones; Zone 4 formation process throughput now exceeds volume requirements for second and potentially third high-volume lines (CEO)
Capital Expenditures: Q4 2025 CapEx expected between $9 million and $12 million, primarily for Fab2 equipment and NPI production line in South Korea (CFO)
Non-GAAP Operating Loss: Q3 2025 non-GAAP loss from operations of $29.8 million (CFO)
Adjusted EBITDA: Improved by $2.3 million year-over-year (10% improvement) in Q3 2025 (CFO)

Official Guidance (Q4 2025):

Revenue: $9.5 million – $10.5 million (CFO) (prepared)
Non-GAAP loss from operations: $30 million – $33 million (CFO) (prepared)
Non-GAAP net loss per share: $0.16 – $0.20 (CFO) (prepared)
Capital expenditures: $9 million – $12 million (CFO) (prepared)
Note: Guidance does not include mass production shipments for any commercial smartphone to Honor in Q4 2025 (CFO)

Mgmt Quotes:

“Revenue grew 85% year-over-year to $8 million. We achieved a non-GAAP gross profit of $1.7 million or 21% margin compared to a loss in the prior year.” (CEO)
“Our AI-1 smartphone battery was validated by an independent testing firm, Polaris Labs, as the highest energy density battery reported for a smartphone battery in the industry.” (CEO)
“We closed the quarter with $648 million in cash, cash equivalents and marketable securities. The goal wasn't just to raise capital. It was to remove what we perceived as a financing overhang… to give our customers comfort in our financial strength.” (CFO)
“With $648 million in cash, we believe we are well positioned to continue executing on our plan, and we remain prepared to pursue strategic opportunities where they meet both our strategic and financial criteria.” (CFO)
“Based on customer feedback, our products are meeting the demanding requirements of this segment, including high pressure tolerance, long cycle life, large capacity formats of up to 60 amp hours that operate reliably in low temperature environments.” (CEO)

Prepared Metrics

Metric	Value	Speaker/Context
Q3 2025 Revenue	$8.0 million	CFO (prepared)
YoY Revenue Growth	+85%	CEO (prepared)
Q3 Non-GAAP Gross Profit	$1.7 million	CEO (prepared)
Q3 Non-GAAP Gross Margin	21%	CEO (prepared)
Q3 Non-GAAP Operating Loss	($29.8 million)	CFO (prepared)
Q3 Non-GAAP Net Loss per Share	($0.14)	CFO (prepared)
Q3 Adjusted EBITDA Improvement	+$2.3 million YoY	CFO (prepared)
Cash, Cash Equivalents & Marketable Securities (End Q3)	$648 million	CEO (prepared)
Year-to-Date Korea Facility Shipments	~$20 million	CEO (prepared)
Defense/Industrial Opportunity Pipeline	>$80 million globally	CEO (prepared)
Warrants Exercised (Program)	~26.5 million shares, ~$224 million net proceeds	CFO (prepared)
Convertible Notes Issued (September 2025)	$360 million, 4.75% due 2030	CFO (prepared)
Q4 2025 Revenue Guidance	$9.5M – $10.5M	CFO (prepared)
Q4 2025 CapEx Guidance	$9M – $12M	CFO (prepared)

Q&A Batch (1–5 of 5)

Q1 — Raj Talluri

Topic: 客户进展、产能布局与无人机市场拓展
Key points:
- 已与2家智能手机OEM签署协议，处于不同验证阶段；已向8家顶级OEM中的7家送样。
- 当完全配备后，现有产线2026年可年产900万块电池；已开始为2号线支付预付款。
- 收到大量无人机OEM兴趣（空中与水下两类），从韩国工厂向韩国国防客户供货，刚收到一家美国国防制造商的新采购订单用于评估。
Mgmt stance: 乐观——产能足以支持客户爬坡，2026年为突破年，无人机市场快速推进。

Q2 — Mark Shooter

Topic: Honor的1,000次循环要求及验证时间线
Key points:
- Honor一直要求1,000次循环；之前样品测试中，双方发现需要一项小设计变更（化学层面，非外形或范围变更）。
- 内部已验证该变更，预计本季度（Q4）向Honor发送新电池；重新测试需3–4个月，预计Q1 2026完成。
- 商业化预计在验证通过后的2026年上半年。
Mgmt stance: 谨慎乐观——团队有信心，但强调首次100%活性硅阳极电池上市需确保完全可靠。

Q3 — George Gianarikas

Topic: 生产爬坡节奏、信心及并购策略
Key points:
- 对当前设计变更有信心，但坚持“100%稳固”才启动量产；另一家客户也在同步测试相同设计迭代，反馈能量密度创基准。
- 资产负债表强劲、资金充足；工厂运行良好，可支撑2026年适时量产。
- 并购方向：可能加速技术普及的渠道、市场进入时间、组件等，但核心使命仍是100%活性硅阳极电池在手机/AR-VR/IoT/计算/部分EV领域的推广。
Mgmt stance: 对核心业务乐观；并购中性偏谨慎——将严格遵循财务与战略纪律。

Q4 — Jeffrey Osborne

Topic: 马来西亚产线良率进展与Honor设计变更细节
Key points:
- 今年因同时生产5–6种不同尺寸样品（手机、智能眼镜、国防等），频繁换线导致未专注优化良率；目前聚焦2款产品（大尺寸手机电池+AR/VR电池）。
- 最近几周激光与堆叠环节良率明显提升，已达到预期；HVM产线将在2026年中后期达到基准良率。
- Honor变更：循环测试趋势显示需修改化学配方（非外形或范围），已内部验证，新样品Q4寄出，重新测试需3–4个月。
Mgmt stance: 中性偏积极——良率方向正确，对按时达成基准有信心。

Q5 — Colin Rusch

Topic: 供应链材料创新与笔记本市场机会
Key points:
- 公司采用“架构优先”策略，可利用更高容量阴极、不同硅阳极（从SiOx转向SiC）及电解液进步；正在测试多种硅碳阳极，已有主供应商并备选第二、第三来源。
- 笔记本市场机会：AI PC需求增长，但公司需专注手机（最难的电池）；一旦手机电池量产，可快速进入计算市场（由多个手机电池组合而成）。
- 目前主动控制团队送样速度，因规模不足以同时支持所有市场。
Mgmt stance: 对材料技术路线乐观；对笔记本市场机会持积极但克制态度——先聚焦1–2个领域做好再扩展。

Q&A Batch (6-7 of 7)

Q6 — Ananda Baruah

Topic: Honor production timeline and second smartphone customer ramp
Key points:
- Initial production volumes with Honor targeted for first half 2026, contingent on successful 1,000-cycle testing.
- Second smartphone customer also targeted for 2026 production, likely later half (fall launch cycle); samples with validated 1,000-cycle chemistry will be provided in Q4 2025.
- Learnings from Honor (drop test, cycle life, fast charge, BMS, temperature/swelling tolerances) are accelerating second customer qualification; requirements are “very similar” across smartphone OEMs.
Mgmt stance: Bullish — management expects first customer to be hardest; subsequent customers will be “a whole lot simpler” due to accumulated know-how and pre-validated chemistry.

Q7 — Derek Soderberg

Topic: Chemistry reformulation timeline, risk of further changes, and revenue breakeven point
Key points:
- Multiple backup chemistries were run in parallel; the chosen reformulation has “very good” results so far, and management does not believe another tweak will be needed.
- Unlike chip design, battery validation requires running 1,000 cycles physically; no simulation shortcut exists.
- Revenue breakeven (non-GAAP gross margin positive) is expected after multiple HVM lines (Line 2, Line 3) are built out in Fab2; adjusted EBITDA positive / cash flow positive requires filling Fab2 to full utilization.
Mgmt stance: Neutral-to-bullish — confident in current chemistry fix but acknowledges the inherent testing timeline; profitability milestones are tied to scale, not near-term.